| Literature DB >> 27771794 |
Daniela Beccati1, Miroslaw Lech1, Jennifer Ozug1, Nur Sibel Gunay1, Jing Wang1, Elaine Y Sun1, Joël R Pradines1, Victor Farutin1, Zachary Shriver1, Ganesh V Kaundinya1, Ishan Capila2.
Abstract
Heparan sulfate (HS), a glycosaminoglycan present on the surface of cells, has been postulated to have important roles in driving both normal and pathological physiologies. The chemical structure and sulfation pattern (domain structure) of HS is believed to determine its biological function, to vary across tissue types, and to be modified in the context of disease. Characterization of HS requires isolation and purification of cell surface HS as a complex mixture. This process may introduce additional chemical modification of the native residues. In this study, we describe an approach towards thorough characterization of bovine kidney heparan sulfate (BKHS) that utilizes a variety of orthogonal analytical techniques (e.g. NMR, IP-RPHPLC, LC-MS). These techniques are applied to characterize this mixture at various levels including composition, fragment level, and overall chain properties. The combination of these techniques in many instances provides orthogonal views into the fine structure of HS, and in other instances provides overlapping / confirmatory information from different perspectives. Specifically, this approach enables quantitative determination of natural and modified saccharide residues in the HS chains, and identifies unusual structures. Analysis of partially digested HS chains allows for a better understanding of the domain structures within this mixture, and yields specific insights into the non-reducing end and reducing end structures of the chains. This approach outlines a useful framework that can be applied to elucidate HS structure and thereby provides means to advance understanding of its biological role and potential involvement in disease progression. In addition, the techniques described here can be applied to characterization of heparin from different sources.Entities:
Keywords: Analytical; Domains; HPLC; Heparan sulfate; MS; NMR; Structure
Mesh:
Substances:
Year: 2016 PMID: 27771794 PMCID: PMC5266780 DOI: 10.1007/s10719-016-9734-7
Source DB: PubMed Journal: Glycoconj J ISSN: 0282-0080 Impact factor: 2.916
Disaccharide composition of BKHS determined by IP-RPHPLC
| Relative Area (%) | |
|---|---|
| ∆UHNAc | 52.3 |
| ∆UgalHNS | 0.5 |
| ∆UHNS(α) | 14.7 |
| ∆UHNS(β) | 1.8 |
| ∆UHNAc6S | 10.4 |
| ∆U2SHNAc (α) | 0.3 |
| ∆U2SHNAc (β) | 0.5 |
| ∆UHNS3S | 0.1 |
| ∆UHNS6S (α) | 5.4 |
| ∆UgalHNS6S (α) | 0.1 |
| ∆UHNS6S (β) | 0.6 |
| ∆U2SHNS (α) | 6.9 |
| ∆U2SHNS (β) | 0.9 |
| ∆U2SHNAc6S(α) | 0.1 |
| ∆U2SHNAc6S(β) | 0.1 |
| ∆UHNAc6SGHNS,3S | 0.5 |
| ∆U2SHNS6S (α) | 4.4 |
| ∆UHNAc6SGHNS3S6S (α) | 0.1 |
| ∆U2SHNS6S (β) | 0.4 |
Fig. 1a 1H–NMR and b HSQC spectra of BKHS. Signals due to the reducing end (xyl α/β and HNAc α), non-reducing end (G n.r.), and differently substituted internal I2S are indicated
Relative percentage of variously substituted glucosamine and uronic acid in BKHS determined by HSQC analysis
| Monosaccharides1 | Composition (mole %) |
|---|---|
| Glucosamine2 | |
| HNS-(I2S) | 11.5 |
| HNS-(I) | 9.6 |
| HNS-(G) | 10.6 |
| HNAc-(G) | 64.8 |
| HNS3S | 0.6 |
| HNH2 | 1.5 |
| HNAc αredox | 1.4 |
| HNX6OH 3 | 75.0 |
| HNX6S 3 | 25.0 |
| Linkage region2 | |
| LR | 4.7 |
| Uronates4 | |
| I2S-(HNS6OH) | 10.1 |
| I2S-(HNS6S) | 7.7 |
| I-(HNX6S)3 | 7.4 |
| I-(HNX6OH)3 | 4.3 |
| G-(HNS)5 | 12.8 |
| G-(HNAc)5 | 57.0 |
| G-(HNS3S)5 | n.d. |
| Epoxide | 0.7 |
| GalA | n.d. |
1Residues reported in brackets indicate the monosaccharide downstream of the quantified glucosamine or uronic acid residue
2Mole % of the total glucosamine content
3X = S or Ac
4Mole % of the total uronic acid content
5 The amount of G at the non-reducing end is calculated as 6.4 % of the total uronic acid content
IP-RPHPLC analysis of BKHS and its fractions (Rel. Area %). Fractions are reported in order of elution: Pool 1 + 2 corresponds to the fraction with the highest MW, Pool 10 to the fraction with the lowest MW. The MW progressively decreases form Pool 1 + 2 to Pool 10
| Chain Region | BKHS | Pool 1 + 2 | Pool 3 | Pool 4 | Pool 5 | Pool 7 | Pool 8 | Pool 10 | |
|---|---|---|---|---|---|---|---|---|---|
| ΔUHNAc | NA domain | 55.2 | 52.0 | 53.5 | 53.5 | 54.3 | 56.4 | 58.1 | 58.1 |
| ΔUHNS | Transition | 17.7 | 20.1 | 19.5 | 19.0 | 18.3 | 17.3 | 16.4 | 15.9 |
| ΔUHNAc6S 1 | Transition | 10.3 | 12.0 | 12.0 | 11.0 | 10.6 | 9.2 | 8.9 | 7.9 |
| ΔUHNS6S | Transition | 6.1 | 6.9 | 6.0 | 6.3 | 6.3 | 6.1 | 5.6 | 6.0 |
| ΔU2SHNS | NS domain | 6.1 | 4.6 | 4.8 | 5.6 | 5.9 | 6.2 | 6.4 | 6.9 |
| ΔU2SHNS6S | NS domain | 4.6 | 4.4 | 4.2 | 4.5 | 4.5 | 4.8 | 4.6 | 5.2 |
1Glucosamine 6-O-sulfotransferase sulfates HNAc residues provided that there is a HNS residue on either the upstream or the downstream disaccharides [35]. According to the enzyme specificity, we can assume that all the ΔUHNAc6S residues are in the transition region or just at the border of it
2 The relative standard deviation (RSD) for the peaks measured by this method is ≤1 %, which basically corresponds to a change in peak area of ±0.6 for the most abundant peak and about ±0.1 or less for the lower abundance peaks. Therefore, the changes observed across fractions are larger than what would be expected by method variability
Relative percentage of N-sulfation vs N-acetylation, 6-O-sulfation, and 2-O-sulfation in BKHS and its fractions (IP-RPHPLC data). Fractions are reported in order of elution: the MW progressively decreases form Pool 1 + 2 to Pool 10
| Intact | Pool 1+ 2 | Pool 3 | Pool 4 | Pool 5 | Pool 7 | Pool 8 | Pool 10 | |
|---|---|---|---|---|---|---|---|---|
|
| 34 | 37 | 35 | 36 | 36 | 34 | 33 | 33 |
|
| 66 | 64 | 66 | 64 | 65 | 66 | 67 | 66 |
| 6- | 21 | 24 | 22 | 22 | 22 | 20 | 19 | 19 |
| 2- | 11 | 9 | 9 | 10 | 10 | 11 | 11 | 12 |
GPC-MS Analysis of non-reducing end residues of BKHS digested by Hep I
| Composition | Relative intensity | Proposed Sequence |
|---|---|---|
| Dp2, Ac0, S1, saturated | 1.14 | G-HNS |
| Dp2, Ac0, S2, saturated | 2.48 | G-HNS6S |
| Dp4, Ac1, S2, saturated | 0.94 | G-HNAc-G1-HNS6S |
| Dp4, Ac0, S3, saturated | 0.42 | G-HNS6X–G/I-HNS6X |
| Dp4, Ac1, S3, saturated | 0.38 | G-HNAc6S–G1-HNS6S |
| Dp4, Ac0, S4, saturated | 0.17 | G-HNS6S–G/I-HNS6S |
| Dp6, Ac1, S3, saturated | 0.13 | G-HNAc6X 2 , 3-G1-HNS6X 2 , 3-G/I-HNS6X |
| Dp6, Ac1, S4, saturated | 0.09 | G-HNAc6X 2 , 3-G1-HNS6S 2 , 3-G/I-HNS6S |
| Dp6, Ac2, S2, saturated | 0.10 | G-HNAc-G1-HNAc6X 2-G-HNS6X |
| Dp8, Ac2, S4, saturated | 0.02 | Not determined |
X = S or OH
1The specificity of the enzymes that synthesize HS suggests that immediately downstream from HNAc there must be a G [51]. Exception have been found, but these structures should constitute a minority
2Glucosamine 6-O-sulfotransferase sulfates HNAc residues provided that there is a HNS residue on either the upstream or the downstream disaccharides
3the positions of HNAc and HNS,6X can be interchanged
GPC-MS Analysis of non-reducing end residues of HS digested by Hep III
| Composition | Relative intensity | Proposed Sequence |
|---|---|---|
| Dp2, 0S, 1Ac, saturated | 0.83 | G-HNAc |
| Dp2, 2S, 0Ac, saturated | 0.25 | G-HNS6S |
| Dp8, 6S, 2Ac, saturated | 0.11 | Not determined |
| Dp8, 7S, 0Ac, saturated | 0.14 | G-(HNS-I2S)3-HNS |
| Dp8, 8S, 0Ac, saturated | 0.21 | G-(HNS6X–I2S)3-HNS6X |
| Dp8, 9S, 0Ac, saturated | 0.12 | G-(HNS6X–I2S)3-HNS6X |
| Dp8, 10S, 0Ac, saturated | 0.07 | G-(HNS6S–I2S)3-HNS |
| Dp10, 9S, 0Ac, saturated | 0.07 | G-(HNS-I2S)4-HNS |
| Dp10, 10S, 0Ac, saturated | 0.09 | G-(HNS6X–I2S)4-HNS6X |
| Dp10, 11S, 0Ac, saturated | 0.04 | G-(HNS6X–I2S)4-HNS6X |
| Dp12, 11S, 0Ac, saturated | 0.02 | G-(HNS-I2S)5-HNS |
| Dp12, 12S, 0Ac, saturated | 0.02 | G-(HNS6X–I2S)5-HNS6X |
X = S or OH